Clinical Trials Browser

Phase 1 × Lymphoma, Large-Cell, Anaplastic × carfilzomib × Clear all

NCT01336920 2023-09-15

Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell